PDE6B and retinal degeneration: A double sgRNA strategy targeting two distinct NRL or NE2E3 sites simultaneously via CRISPR/Cas9 knockout at P7 revealed increased expression of the cone marker mouse cone arrestin when injected in wild-type (wt) mice and increased ONL thickness in 2 different Pde6β-/- retinal degeneration mouse models [77].